Could Breast Cancer Radiation Lower Alzheimer’s Risk?

In a discovery that blurs the lines between oncology and neurology, researchers in South Korea have found that radiation therapy — a standard treatment for breast cancer — may offer an unexpected short-term benefit: a lower risk of developing Alzheimer’s disease.

The study, led by scientists at Samsung Medical Center and published in JAMA Network Open, analyzed data from over 70,000 breast cancer survivors, comparing them to nearly 180,000 women without a history of breast cancer. All participants were tracked for up to 11 years using data from the Korean National Health Insurance Service.

What stood out was that women who received radiation therapy as part of their cancer treatment were 8% less likely to be diagnosed with Alzheimer’s in the years that followed. And while that might sound modest, the size of the population studied gives the findings considerable weight.

Breast cancer remains one of the most prevalent cancers worldwide — one in eight women in the U.S. will be diagnosed in their lifetime. Meanwhile, Alzheimer’s is a mounting crisis, affecting an estimated seven million Americans today. The question of how these two health challenges might intersect is gaining traction in research circles.

“There’s long been concern that cancer treatments might harm long-term cognition,” said study co-author Dr. Soo-Jin Lee. “We wanted to test whether those concerns translate into a measurable risk of Alzheimer’s.” What they found, at least in the case of radiation, was quite the opposite.

The link to radiation is particularly intriguing. Among the cancer survivors studied, 72% had undergone radiotherapy, and many of them saw a reduction in Alzheimer’s risk — though that benefit appeared to wane over time. The researchers believe this points to a possible early protective mechanism that fades as the years go on.

Experts not involved with the study are cautiously intrigued. Dr. Jon Stewart Hao Dy, a board-certified neurologist, points to possible anti-inflammatory effects of radiation on the brain. “There’s growing evidence that radiation might tamp down harmful immune activity — like astrogliosis or microgliosis — that’s associated with neurodegeneration,” Dy said.

Dr. Rizwan Bashir, another neurologist, agrees that the immune angle is promising. “It’s possible that radiation impacts the body’s immune environment in a way that reduces amyloid plaque buildup,” he explained, referencing the sticky protein clumps often seen in Alzheimer’s brains. He also highlighted hormone therapy — frequently used in breast cancer treatment — as another potential factor. “Estrogen’s role in brain aging is complicated. Lowering estrogen might paradoxically reduce Alzheimer’s risk for certain women,” Bashir noted.

The researchers caution that their study can’t prove cause and effect. And while radiation showed a statistically significant association with lower Alzheimer’s risk, other breast cancer treatments — like chemotherapy and hormone therapy — didn’t yield similar results in this dataset.

Importantly, the benefit observed with radiation seemed to be time-limited. “The effect appears strongest shortly after treatment and seems to diminish over the years,” the authors wrote. “This may suggest that certain biological processes are temporarily disrupted in ways that benefit brain health, but these changes may not be sustained.”

Still, the findings open an important door. With both cancer and Alzheimer’s on the rise globally, uncovering possible overlaps in treatment effects could be a powerful tool for prevention — or at the very least, a reason to rethink how we monitor cognitive health in cancer survivors.

“The idea that radiation, typically seen as a double-edged sword, might briefly protect the brain is not something we anticipated,” said Dr. Bashir. “It challenges our assumptions and encourages us to look deeper.”

Longer-term studies are already underway to see whether these findings hold up across different populations and time spans. For now, the message is clear: treatments aimed at one part of the body might be quietly rewriting the script for another.